Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression

Depression and Anxiety

Volumn 13, Issue 3, 2001, Pages 125-131

  Flint, Alastair J ^a,b   Rifat, Sandra L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Antidepressant medication; Geriatric depression; Recurrence; Relapse; Treatment resistance

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PHENELZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; GERONTOPSYCHIATRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; RELAPSE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; NORTRIPTYLINE; PHENELZINE; RECURRENCE; RISK; TREATMENT FAILURE;

EID: 0035020845     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.1028     Document Type: Article

References (31)

1. Alexopoulos GS, Young RC, Abrams RC, Meyers B, Shamoian CA. 1989. Chronicity and relapse in geriatric depression. Biol Psychiatry 26:551-564.
2. Baldwin RC, Simpson S. 1997. Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease. J Affect Disord 46:163-173.
3. Burvill PW, Mowry B, Hall WD. 1990. Quantification of physical illness in psychiatric research in the elderly. Int J Geriatr Psychiatry 5:161-170.
4. Flint AJ. 1997. Pharmacologic treatment of depression in late life. Can Med Assoc J 157:1061-1067.
5. Flint AJ, Rifat SL. 1996. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 36:95-105.
6. Flint AJ, Rifat SL. 1997a. Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 5:107-115.
7. Flint AJ, Rifat SL. 1997b. Two-year outcome of elderly patients with anxious depression. Psychiatry Res 66:23-31.
8. Flint AJ, Rifat SL. 1997c. The effect of treatment on the two-year course of late-life depression. Br J Psychiatry 170:268-272.
9. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
10. Georgotas A, Friedman E, McCarthy M, Mann J, Krakowski M, Siegel R, Ferris S. 1983. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Biol Psychiatry 18:195-205.
11. Goergotas A, McCue RE, Cooper TB, Nagachandran N, Chang I. 1988. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate. Arch Gen Psychiatry 45:929-932.
12. Georgotas A, McCue RE, Cooper TB. 1989. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 46:783-786.
13. Guscott R, Grof P. 1991. The clinical meaning of refractory depression: a review for the clinician. Am J Psychiatry 148:695-704.
14. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
15. Keller MB, Boland RJ. 1998. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 44:348-360.
16. Lavori PW, Keller MB, Mueller TI, Scheftner W, Fawcett J, Coryell W. 1994. Recurrence after recovery in unipolar MDD: an observational followup study of clinical predictors and somatic treatment as a mediating factor. Int J Methods Psychiatr Res 4:211-229.
17. Little JT, Reynolds CF, Dew MA, Frank E, Begley AE, Miller MD, Cornes C, Mazumdar S, Perel JM, Kupfer DJ. 1998. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? Am J Psychiatry 155:1035-1038.
18. Meyers BS, Gabriele M, Kakuma T, Ippolito L, Alexopoulos G. 1996. Anxiety and depression as predictors of recurrence in geriatric depression: a preliminary report. Am J Geriatr Psychiatry 4:252-257.
19. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorders: follow up study. BMJ 317:982-984.
20. Old Age Depression Interest Group. 1993. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 162:175-182.
21. Reynolds CF. 1997. Treatment of major depression in later life: a life cycle perspective. Psychiatr Quart 68:221-246.
22. Reynolds CF, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ. 1999. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281:39-45.
23. Robinson DS, Lerfald SC, Bennett B, Laux D, Devereaux E, Kayser A, Corcella J, Albright D. 1991. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. Psychopharmacol Bull 27:31-39.
24. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. 1990. The impact of medication resistance and continuation pharamcotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10:96-104.
25. Simpson S, Baldwin RC, Jackson A, Burns AS. 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in latelife depression. Psychol Med 28:1015-1026.
26. Spitzer RL, Williams JBW, Gibbons M. 1986. Structured clinical interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, Biometrics Research.
27. Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ. 1992. Treatment of imipramine-resistant recurrent depression. III. Efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 53:5-11.
28. Thase ME, Rush AJ, Kasper S, Nemeroff CB. 1994/1995. Tricyclics and newer antidepressant medications: treatment options for treatment-resistant depression. Depression 2:142-168.
29. Thase ME, Trivedi MH, Rush AJ. 1995. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 12:185-219.
30. Yanai I, Fujikawa T, Horiguchi J, Yamawaki S, Touhouda Y. 1998. The 3-year course and outcome of patients with major depression and silent cerebral infraction. J Affect Disord 47:25-30.
31. Zigmond AS, Snaith RP. 1983. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370.